Cargando…

Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma

Insulin-like growth factor-II mRNA-binding protein 3 (IMP3) has been recently identified as a marker of aggressive behavior in several types of tumors. The aim of the present study was to detect the expression of the IMP3 protein in colorectal adenocarcinoma (CRA) and to identify a correlation with...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIN, LIJUAN, ZHANG, JINHUI, WANG, YAN, JU, WEIEI, MA, YIBING, LI, LINA, CHEN, LITIAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789059/ https://www.ncbi.nlm.nih.gov/pubmed/24137402 http://dx.doi.org/10.3892/ol.2013.1458

Ejemplares similares

Clinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinoma
por: ZHANG, JINHUI, et al.
Publicado: (2015)

Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma
por: Sheen, Yi-Shuan, et al.
Publicado: (2016)

A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer
por: Di Fusco, Davide, et al.
Publicado: (2023)

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
por: Schaeffer, David F, et al.
Publicado: (2010)

Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis
por: Zeng, Changqing, et al.
Publicado: (2017)

Insulin-Like Growth Factor Binding Protein-2 Promotes Proliferation and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ma, Yang, et al.
Publicado: (2020)

Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine
por: Daikuhara, Seiichi, et al.
Publicado: (2015)

TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma.
por: Powe, D. G., et al.
Publicado: (1997)

Absence of Autophagy-Related Proteins Expression Is Associated with Poor Prognosis in Patients with Colorectal Adenocarcinoma
por: Choi, Ji Hye, et al.
Publicado: (2014)

Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma
por: Yan, Jinjin, et al.
Publicado: (2017)

Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020)

LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis
por: Xie, Jian, et al.
Publicado: (2021)

Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma
por: Liu, Can-Tong, et al.
Publicado: (2020)

Inhibition of insulin‐like growth factor 2 mRNA‐binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics
por: Betson, Nicole, et al.
Publicado: (2022)

Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
por: Park, Youn Young, et al.
Publicado: (2019)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Elevated insulin-like growth factor 2 mRNA binding protein 1 levels predict a poor prognosis in patients with breast carcinoma using an integrated multi-omics data analysis
por: Li, Shiqi, et al.
Publicado: (2022)

Decreased Expression of the Polarity Regulatory PAR Complex Predicts Poor Prognosis of the Patients with Colorectal Adenocarcinoma()()
por: Yeo, Min-Kyung, et al.
Publicado: (2017)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis
por: Doldo, Elena, et al.
Publicado: (2015)

Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2018)

Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
por: Renehan, A G, et al.
Publicado: (2000)

Insulin-like growth factor II mRNA-binding protein 3 promotes cell proliferation, migration and invasion in human glioblastoma
por: Wu, Chao, et al.
Publicado: (2019)

Grainyhead-like 2 Promotes Tumor Growth and is Associated with Poor Prognosis in Colorectal Cancer
por: Quan, Yingjun, et al.
Publicado: (2015)

Increased PYCR1 mRNA predicts poor prognosis in kidney adenocarcinoma: A study based on TCGA database
por: Zhang, Tianyi, et al.
Publicado: (2021)

A gene mutation in RNA-binding protein 10 is associated with lung adenocarcinoma progression and poor prognosis
por: Yin, Lin-Lin, et al.
Publicado: (2018)

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
por: Xu, Zhangyan, et al.
Publicado: (2020)

Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA
por: Di Fusco, Davide, et al.
Publicado: (2023)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
por: Zong, Meijuan, et al.
Publicado: (2011)

Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancer
por: Kasprzak, Aldona, et al.
Publicado: (2012)

Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma
por: Ha, Yun-Sok, et al.
Publicado: (2014)

High expression of guanine nucleotide-binding protein-like-3-like is associated with poor prognosis in esophageal cancer
por: Dai, Guihong, et al.
Publicado: (2021)

High expression of Krüppel‐like factor 5 is associated with poor prognosis in patients with colorectal cancer
por: Takagi, Yutaka, et al.
Publicado: (2020)

The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer
por: Dahlem, Charlotte, et al.
Publicado: (2019)

Serum Insulin-Like Growth Factor Binding Protein 7 for Esophagogastric Junction Adenocarcinoma Diagnosis
por: Zhang, Gao-Ming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l6hg1ctntbm8j4n1j63isll7un